VivoSeq
Other

Mesenchymal Stromal Cells

0

Pipeline Programs↗

10

Active Trials↗

0

Companies Involved↗

Mesenchymal Stromal Cells is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

27/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

75/100

Attrition Rate

10/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

30

clinical trials

Completed9 · 30%
Unknown status8 · 27%
Recruiting5 · 17%
Active, not recruiting4 · 13%
Terminated2 · 7%
Withdrawn1 · 3%
Other1 · 3%

Clinical Trials

Trial Activity

30 trials

A Trial to Evaluate the Safety and Preliminary Efficacy of iMesenchymal Stromal Cells(iMSC) in Subjects With SR-aGVHD
Recruiting·—·N/A·NCT06321198·12 enrolled
Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT
Recruiting·MMedical University of South Carolina·Phase 1·NCT05095532·42 enrolled
Efficacy of Locally Delivered Allogeneic Mesenchymal Stromal Cells
Recruiting·UUniversity of Illinois at Chicago·Phase 2·NCT05705024·38 enrolled
Safety of Endobronchial Mesenchymal Stromal Cells in the Treatment of Chronic Lung Allograft Dysfunction
Recruiting·IInstituto De Investigación Sanitaria Puerta De Hierro-Segovia De Arana·Phase 1·NCT06514378·12 enrolled
LYell SYndrome MEsenchymal Stromal Cells Treatment
Recruiting·AAssistance Publique - Hôpitaux de Paris·Phase 1/2·NCT04711200·15 enrolled
Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Therapy-resistant CVU (Phase III)
Active, not recruiting·RRHEACELL GmbH & Co. KG·Phase 3·NCT06489028·250 enrolled
Use of Allogeneic Extracellular Secretomes (EV)Derived From Umbilical Cord Mesenchymal Stromal Cells: a Phase I Open-label Safety Trial.
Active, not recruiting·UUniversity of Jordan·Phase 1·NCT06813027·13 enrolled
The Use of Expandeded Mesenchymal Stromal Cells (MSC) in Premature Ovarian Failure (POF) in Adult Humans
Active, not recruiting·UUniversity of Jordan·Phase 1·NCT04815213·10 enrolled
Selected Mesenchymal Stromal Cells to Reduce Inflammation in Patients With PSC and AIH
Active, not recruiting·UUniversity of Birmingham·Phase 1/2·NCT02997878·18 enrolled
Wharton Jelly Mesenchymal Stromal Cells as GVHD Prophylaxis
Not yet recruiting·—·Phase 1·NCT05855707·12 enrolled
Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells
Completed·UUniversity of Illinois at Chicago·Phase 1·NCT04626583·8 enrolled
Subarachnoid Administrations of Adults Autologous Mesenchymal Stromal Cells in SCI
Completed·PPuerta de Hierro University Hospital·Phase 1·NCT02165904·10 enrolled
An Australian Study of Mesenchymal Stromal Cells for Crohn's Disease
Completed·RR.P.Herrmann·Phase 2·NCT01090817·21 enrolled
Trial of Bone-marrow Derived Mesenchymal Stromal Cells (MSC) for New Onset Chronic Lung Allograft Dysfunction
Completed·TThe University of Queensland·Phase 2·NCT02709343·64 enrolled
Evaluation of Autologous Adipose Derived Mesenchymal Stromal Cells (AD-MSC) Transplantation in Ultra Filtration Failure (UFF)
Completed·RRoyan Institute·Phase 1/2·NCT02801890·10 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)